# Treatment of Hemoglobin SC Disease With Hydroxyurea

> **NCT02336373** · PHASE2 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 32 (actual)

## Conditions studied

- Hemoglobin SC Disease

## Interventions

- **DRUG:** hydroxyurea

## Key facts

- **NCT ID:** NCT02336373
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2017-02
- **Final completion:** 2017-03-31
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** low enrollment
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336373, "Treatment of Hemoglobin SC Disease With Hydroxyurea". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02336373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*